Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Leveljump HealthcareJMPHF EV-to-EBITDA is 12.96 as of Jul. 31, 2026. The stock has 1 warning sign investors should review. Among 119 Medical Diagnostics & Research companies, Leveljump Healthcare ranks better than 77.31% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Leveljump Healthcare's enterprise value is $10.76 Mil.
Leveljump Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $0.83 Mil. Therefore, Leveljump Healthcare's EV-to-EBITDA for today is 12.96.
The historical rank and industry rank for Leveljump Healthcare's EV-to-EBITDA or its related term are showing as below:
JMPHF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -31.1 Med: -2.61 Max: 18.12
Current: 13.2
During the past 7 years, the highest EV-to-EBITDA of Leveljump Healthcare was 18.12. The lowest was -31.10. And the median was -2.61.
JMPHF's EV-to-EBITDA is ranked better than 77.31% of 119
companies
in the Medical Diagnostics & Research industry
Industry Median: 15.76
vs JMPHF: 13.20
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Leveljump Healthcare's PE Ratio (TTM) for today is calculated as:
Leveljump Healthcare's share price for today is $0.04275.
Leveljump Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.027.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Leveljump Healthcare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Leveljump Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leveljump Healthcare EV-to-EBITDA vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Leveljump Healthcare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Leveljump Healthcare's EV-to-EBITDA falls into.
Leveljump Healthcare's current Enterprise Value is $10.76 Mil.
Leveljump Healthcare's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.83 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leveljump Healthcare (JMPHF) has a EV-to-EBITDA of 12.96 as of Jul. 31, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Leveljump Healthcare. According to the industry distribution chart, Leveljump Healthcare ranks #27 out of 119 companies in the Medical Diagnostics & Research industry, placing it in the top 22.7%.
Is Leveljump Healthcare's EV-to-EBITDA too high?
Leveljump Healthcare's current EV-to-EBITDA is 12.96. The Medical Diagnostics & Research industry median EV-to-EBITDA is 15.76. Leveljump Healthcare's value of 12.96 is 17.8% below this industry median. Based on the distribution chart, Leveljump Healthcare ranks #27 out of 119 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers.
How does Leveljump Healthcare's EV-to-EBITDA compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Leveljump Healthcare ranks #27 out of 119 companies for EV-to-EBITDA. This places Leveljump Healthcare in the top 23% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 15.76. Leveljump Healthcare's value of 12.96 is 17.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Diagnostics & Research company?
The median EV-to-EBITDA among Medical Diagnostics & Research companies is 15.76, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leveljump Healthcare's current EV-to-EBITDA of 12.96 is 17.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Leveljump Healthcare. For the Medical Diagnostics & Research industry, the median EV-to-EBITDA is 15.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leveljump Healthcare's current EV-to-EBITDA is 12.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leveljump Healthcare stock overvalued right now?
Leveljump Healthcare (JMPHF) has a current EV-to-EBITDA of 12.96. The stock's GF Value™ is $0.05, compared to a current price of $0.04 — trading 14.5% below its estimated fair value. The current EV-to-EBITDA is 12.96 and 17.8% below the Medical Diagnostics & Research industry median of 15.76. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Leveljump Healthcare (JMPHF), the current EV-to-EBITDA is 12.96 as of Jul. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Leveljump Healthcare Corp is engaged in providing radiology services both by providing direct patient images and by providing Teleradiology services, which is the process of providing remote off-site reading of radiology scans such as CT, MRI, and X-ray. Its teleradiology services allow hospital staff to scan their emergency room patients, then page the company's radiologist on call, who can then remotely view, via a secured server, the images and diagnose the patient, and provide a report back to the hospital. Leveljump provides its direct-to-patient services at its Independent Healthcare Facilities (IHFs). The company operates as a single segment, with all of its core assets, intellectual property, and development work being conducted in Canada.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JMPHF has been successfully added to your 
